Promising Peptides
Peptides To Watch: Six Compounds Beyond The Core Range
The research field moves faster than any catalogue. Beyond the proven core range, six peptides keep surfacing in the literature and in lab conversations. Here is what each one is studied for, and why they sit on our radar.
The ONE% catalogue is deliberately narrow, built from compounds that earn their place by documented proof. But the research landscape is far wider than any single range, and part of doing this well is watching what comes next. The six peptides below are not on our shelves today. They are on our radar: actively studied, frequently cited, and worth understanding for anyone tracking where the field is heading. Think of this as a field guide to the watchlist rather than a shopping list.
Key Takeaways
- Semax and Selank are short neuropeptides studied for cognition, attention and stress-response signalling.
- Epithalon and Thymosin Alpha-1 anchor bodies of longevity and immune-signalling research respectively.
- AOD-9604 and PT-141 sit on the metabolic and specialty fringe, earlier in the proof cycle than the core range.
- These compounds are watched for promise; the core ONE% range is stocked only once it clears the proof bar.
Beyond The Staples
A narrow catalogue is a discipline, not a shortage of ideas. Every compound in the ONE% range had to answer for itself with independent testing before it was listed. That same discipline is what keeps the following six off the shelf for now. They are promising, and in several cases heavily researched, but a watchlist entry is a statement of interest, not a claim of proof.
Understanding them is still worthwhile. Reading the fringe of a field is how you learn where the settled part came from, and each of these appears often enough in the literature to be worth knowing by name. For the mechanism-level background that underpins all of them, our how peptides work guide is the place to start.
The core range earns its place by proof. The watchlist earns its place by promise, and the two should never be confused.
The Neuro Set: Semax And Selank
Semax and Selank are the two names that come up most in the neuro-research corner of the peptide world. Both are short, synthetic peptides derived from naturally occurring sequences, and both are studied as tools for probing brain signalling rather than as blunt instruments.
Semax is investigated in research around cognition, attention and neuroprotection, with a literature that points toward its effects on neurotrophic signalling. Selank sits closer to the anxiety and stress-response side, studied for how it modulates the pathways involved in the regulation of calm and focus. Their shared appeal is precision: a comparatively clean, targeted way to interrogate specific signalling routes. We cover both in depth in our dedicated piece on Semax and Selank.
Longevity And Immune: Epithalon And Thymosin Alpha-1
Two compounds anchor the longevity and immune corners of the watchlist. Epithalon, a four-amino-acid peptide, appears repeatedly in ageing research, most intriguingly in work touching on telomere biology and the enzyme telomerase. It is one of the more provocative names in the space precisely because the questions it raises are unresolved, which is exactly what makes it a research compound rather than a settled one. Our article on Epithalon and the telomere question examines what the studies do and do not show.
Thymosin Alpha-1 comes from a different tradition entirely. It anchors a large and mature body of immune-signalling research, studied for its role in modulating T-cell activity and the broader immune response. Where Epithalon is speculative and early, Thymosin Alpha-1 is a well-established reference compound in its niche, which is why the two so often sit side by side on a watchlist despite pointing in different directions.
The Metabolic And Specialty Fringe: AOD-9604 And PT-141
The last two are the furthest from the settled core. AOD-9604 is a fragment of the growth-hormone molecule, studied in metabolic research for the signalling associated with fat metabolism without the full hormonal activity of the parent peptide. It is an interesting scalpel, and still earlier in the proof cycle than anything currently in the range.
PT-141, also known as bremelanotide, works on the melanocortin pathway and features in studies of sexual-function signalling, a mechanism distinct from the vascular route most associated with that area of research. Both AOD-9604 and PT-141 illustrate why the watchlist exists: genuinely interesting directions that have not yet accumulated the depth of documentation ONE% requires before a compound joins the line.
Watchlist Versus Range
The distinction is the whole point. A compound moves from this article to the store only when it can be held to the greater than 99% purity target and backed by independent mass-spec and HPLC on every batch. Interest is not evidence, and promise is not proof. The gap between the two is exactly the space this watchlist occupies, and the standard that closes it is documented on our lab testing and COA page.
Frequently Asked Questions
Are these six peptides available from ONE%?
No. This is a watchlist, not a product list. These compounds are actively studied and worth understanding, but they are not part of the ONE% range, which is stocked only once a compound clears the proof and purity bar we apply to everything we list.
What is the difference between the watchlist and the core range?
The core range earns its place by documented proof: independent mass-spec and HPLC on every batch, held to a greater than 99% purity target. The watchlist earns its place by promise, meaning active research interest that has not yet accumulated the depth of documentation required to join the line.
Why are Semax and Selank grouped together?
Both are short neuro-active peptides studied as targeted tools for probing brain signalling. Semax features more in cognition and neuroprotection research while Selank sits closer to stress-response work, but their shared precision and origin make them a natural pair on any watchlist.
What makes Epithalon of interest in longevity research?
Epithalon is a short peptide that recurs in ageing research, most notably in studies touching telomere biology and the enzyme telomerase. The questions it raises are unresolved, which is what keeps it firmly in the research category rather than a settled one.
Could any of these join the ONE% range later?
Potentially. A watchlist entry is a statement of interest. If a compound accumulates the research depth and can be held to the purity and documentation standard applied across the range, it becomes a candidate for the line. Until then it stays on the watchlist.
Start With The Proven Range
Shop ONE%
Keep Reading
More From Education
How We Built ONE%: One Standard, Every Batch
The peptide market is full of claims nobody documents. We set out to build the opposite, and to show our work.
Semax & Selank: The Neuropeptides On Every Watchlist
Two short peptides from the neuro-research world that keep appearing in conversations about cognition and stress.
Epithalon And The Telomere Question
A four-amino-acid peptide that keeps turning up in longevity research, and the intriguing question it raises about telomeres.